# Argan Inc. (AGX) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Industrials / Construction & Engineering. Price $417.99, market value $5.9 billion.

## Valuation
- **P/E (trailing): 33.0×** (5-yr avg 21.2×, 3-yr avg 25.2×). Argan Inc. trades at 33.0× trailing earnings, well above its own five-year average of 21.2×: investors are paying up relative to the company's past. The Industrials median in the September 2026 study was 25.7×. Forward P/E is 26.5×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.45**. A PEG of 0.45 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 4.9×**. Each dollar of revenue is priced at 4.9×.
- **Price / book: 11.6×**. The shares trade at 11.6× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Free-cash-flow yield: 9.3%** (5-yr avg 7.0%). Free cash flow equals 9.3% of the market value, above its five-year average of 7.0%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 3.0%**. The inverse of the P/E: 3.0% of the price is earned each year.

## Profitability
- **Gross margin: 20.9%**. Argan Inc. keeps 20.9% of revenue after the direct cost of what it sells, a thin margin typical of retail, distribution and commodity businesses.
- **Operating margin: 15.4%**. 15.4% of revenue is left after running the business, a healthy level in most sectors.
- **Net margin: 14.6%**. 14.6% of each dollar of sales reaches the bottom line.
- **Return on equity: 29.8%**. 29.8% on shareholders' equity is excellent if it is not driven by leverage; sustained above 20% usually signals a competitive advantage.
- **Return on assets: 15.1%**. Each dollar of assets produces 15.1% of profit.

## Growth
- **Revenue growth (1 yr): 8.1%** (3-yr 27.6%/yr, 5-yr 19.2%/yr). Revenue grew 8.1% over the last year, against 19.2% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 58.4%** (3-yr 61.1%/yr, 5-yr 45.2%/yr). Earnings per share rose 58.4%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Current ratio: 1.59** (quick 1.59). Current assets cover the next year's liabilities 1.59 times.
- **Altman Z-score: 7.00**. A Z-score of 7.00 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 0.48%** ($2.00 per share, trailing). Argan Inc. yields 0.48%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 18%** (5% of free cash flow). 18% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 4**. 4 straight years of increases.
- **Dividend growth (5 yr): -12.9%/yr** (1-yr 27.5%). The dividend has not grown over five years.

## Analyst view
- **Analyst consensus: buy** (5 analysts). 5 analysts cover Argan Inc.; the consensus is buy, with an average price target of $667.80 (+60% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 76.6%** (YTD 33.8%, 3-mo -39.8%). The shares are up 76.6% over twelve months including dividends.
- **From 52-week high: -48.1%** (106.7% above the low). Trading 48% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 31**. An RSI of 31 is neutral.
- **Beta (1 yr): 1.90** (volatility 80%). Beta of 1.90 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=AGX · Page: https://foliofundamentals.com/stocks/agx

Not investment advice.